✦ LIBER ✦

Pegylated 40KDA IFN alfa-2a plus amantadine (AMA) or ribavirin (RBV) in naives with chronic hepatitis C (CHC): the HIMPCT (Hepatitis Italian Multicenter Pegasys Amantadine Cooperative Trial)

✍ Scribed by Gaetano Ideo; Mario Angelico; A. Chirianni; Antonio Craxi; G. Di Perri; L. Minoli; Giuseppe Montalto; Antonio Picciotto; Mario Rizzetto; Giuseppe Ruggiero; A. Scalzini; Massimo Sarracino

Book ID: 118565312
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 111 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80396-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1186 PEG-IFN alfa-2A (40KD) (PEGASYS) pl

1186 PEG-IFN alfa-2A (40KD) (PEGASYS) plus amantadine (AMA) or ribavirin (RBV) in naive patients with chronic hepatitis C (CHC)

✍ IDEO, G; ATTILI, A; BABUDIERI, S; CHIRIANNI, A; CRAXI, A; DIPERRI, G; FRANCAVILL 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

PEG-IFN alfa-2a (40kd) (Pegasys) plus am

PEG-IFN alfa-2a (40kd) (Pegasys) plus amantadine (AMA) or ribavirin (RBV) in naïve patients with chronic hepatitis C (CHC)

✍ G. Ideo; A. Attili; G. Ruggiero; A. Craxi; G. Di Perri; A. Mangia; A. Picciotto; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Peginterferon alfa-2A (40KD) (PEGASYS) p

Peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (roferon-A) plus RBV and AMA in IFN/RBV nonresponder patients with chronic hepatitis C (CHC)

✍ S. Fargion; M. Borzio; A. Cargnel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 312 KB

475 Sustained virological response (SVR)

475 Sustained virological response (SVR) to peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (Roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C (CHC)

✍ S. Fargion; M. Borzio; A. Maraschi; A. Cargnel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

1194 End of treatment and sustained resp

1194 End of treatment and sustained response to peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) (COPEGUS) and amantadine (AMA), and to induction therapy with interferon (IFN) alfa-2A (ROFERON-A) plus RBV and AMA in IFN/RBV nonresponders with chronic hepatitis C (CHC)

✍ FARGION, S; BORZIO, M; CARGNEL, A 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

A randomised controlled trial on pegylat

A randomised controlled trial on pegylated interferon alfa-2a (40kd) (Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV

✍ A. Mangia; G.L. Ricci; N. Minerva; M. Persico; V. Carretta; D. Bacca; M. Cela; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 145 KB